The landscape of healthcare communications is undergoing a profound transformation as the demand for sophisticated, compliant, and highly creative brand experiences reaches an all-time high. With the recent formation of IdentityCoda, a powerhouse merger between a global experience agency and a specialist healthcare communicator, the industry is witnessing a new standard for how scientific innovation is presented to the world. Our hospitality and events expert, Katarina Railko, brings her extensive background in travel, tourism, and large-scale expos to analyze how this evolution impacts the pharmaceutical sector. This conversation explores the synergy of global infrastructure and technical precision, the complexities of maintaining regulatory compliance across borders, and the nuances of scientific storytelling in an era where digital and physical worlds collide.
With the formation of IdentityCoda, how will the integration of global infrastructure and technical innovation specifically enhance the delivery of congress programs and satellite symposia? What specific steps are taken to ensure that creative clarity is maintained when translating complex scientific data into these large-scale live experiences?
The integration of a global delivery network allows us to scale technical excellence in ways that were previously impossible for boutique agencies. By leveraging Identity’s vast infrastructure, we can deploy advanced production resources that ensure every satellite symposium feels like a high-stakes theatrical event rather than a dry lecture. We focus on “creative clarity” by building environments where scientific expertise can truly shine, utilizing sophisticated visual tools to unpack dense data sets. Since Coda was founded in 2015, the mission has always been to transform complex science into something tangible and engaging, and now, with an expanded resource pool, we can do this across multiple global markets simultaneously. This ensures that whether a doctor is attending a congress in Europe or North America, the core scientific message remains consistent, vibrant, and easy to digest.
Pharmaceutical organizations face increasingly rigorous compliance oversight when managing international investigator meetings and advisory boards. How does your combined strategic consultancy approach mitigate these regulatory risks, and could you share a scenario where this precision directly impacted the success of a global healthcare event?
Navigating the labyrinth of international regulations requires a deep-seated strategic consultancy approach that bridges the gap between creative ambition and strict compliance. Our teams work as integrated partners to ensure that every investigator meeting or advisory board adheres to the specific legal frameworks of the host country, which is vital when operating across our hubs in the UK and Portugal. This precision is not just about following rules; it is about protecting the integrity of the research and the reputation of the pharmaceutical giants who trust us with their data. By providing end-to-end support, we mitigate risks early in the planning phase, ensuring that the “high impact” experiences we create never compromise the rigorous standards required by the healthcare sector. The success of these global events often hinges on this invisible layer of compliance, allowing participants to focus entirely on the scientific breakthroughs being shared.
The transition to hybrid and virtual healthcare events requires a delicate balance of content production and scientific storytelling. What specific metrics do you use to measure audience understanding in these formats, and how has the expansion into North American and Middle Eastern markets influenced your design of brand experiences?
Measuring understanding in a hybrid environment goes beyond simple attendance numbers; we look at how deeply an audience engages with the “scientific storytelling” through interactive content and real-time feedback loops. Our expansion into the Middle East and North America has forced us to become even more culturally and technically agile, designing brand experiences that resonate across different professional expectations. We utilize sophisticated content production techniques to ensure that a virtual attendee feels the same pulse and energy as someone standing on the exhibition floor. This global reach means we are constantly refining our metrics to track how effectively we are uniting diverse audiences around a single scientific truth. The goal is to drive a shared understanding that transcends the screen, making the digital experience feel as visceral and memorable as a face-to-face encounter.
Internal leadership programs often require a different creative touch than external exhibition designs. How does your expanded resource pool allow for more ambitious internal communication strategies, and what is your process for maintaining personal attention while scaling operations across offices in the UK and Portugal?
Internal communication requires a specialized focus on human connection, often demanding a more intimate and strategic creative touch than the grand scale of a public exhibition. With our dual-base operations in Cheshire, UK, and Coimbra, Portugal, we are able to draw from a wider talent pool to design leadership programs that feel bespoke and personal, even when executed for thousands of employees. We maintain this “personal attention” by assigning dedicated specialist teams who act as an extension of the client’s internal culture, ensuring the precision of the message is never lost. Our expanded resources mean we can be more ambitious with the technology we use for internal events, turning a standard corporate meeting into a transformative experience for the workforce. This balance of global scale and boutique-level care is what allows us to support the internal mission of healthcare organizations as they push scientific boundaries.
As the industry enters a self-described golden age of experience, how are you evolving your end-to-end support to meet the demand for integrated partnerships? What technical or production resources are now most critical for healthcare organizations navigating these complex communication challenges?
We are currently navigating what our leadership calls the “Golden Age of Experience,” where the rate of change is accelerating and the expectations for integrated partnerships are higher than ever. To meet this demand, we have evolved our end-to-end support to include everything from strategic consultancy to the most advanced exhibition design and brand experiences. Technical innovation is now a critical resource, specifically in how we use data visualization and immersive production to solve complex communication challenges for pharmaceutical clients. Organizations need partners who can offer a seamless bridge between the technical, the creative, and the compliant, and our integrated model provides that exact stability. By providing immediate access to expanded creative and production resources, we empower our clients to be more daring in how they present their research to the world.
What is your forecast for the future of healthcare communications and experiential events?
The future of healthcare communications will be defined by a shift toward even more integrated, “borderless” experiences where the distinction between physical and digital presence becomes almost irrelevant. We anticipate a surge in demand for highly specialized agencies that can handle the massive scale of global congresses while maintaining the surgical precision required for medical compliance. As technology continues to evolve, scientific storytelling will become more immersive, allowing stakeholders to “step inside” data in ways we are only beginning to explore. Healthcare organizations will increasingly seek out partners who can provide a global delivery network, ensuring that vital medical advancements are communicated with the clarity, speed, and emotional resonance they deserve. This is a time of incredible opportunity, where the intersection of science and experience will drive a deeper global understanding of the treatments that save lives.
